KR102186403B1 - Method for Treating Cancer Using Alternative Electric Field in Combination with Radiation Therapy - Google Patents
Method for Treating Cancer Using Alternative Electric Field in Combination with Radiation Therapy Download PDFInfo
- Publication number
- KR102186403B1 KR102186403B1 KR1020150125412A KR20150125412A KR102186403B1 KR 102186403 B1 KR102186403 B1 KR 102186403B1 KR 1020150125412 A KR1020150125412 A KR 1020150125412A KR 20150125412 A KR20150125412 A KR 20150125412A KR 102186403 B1 KR102186403 B1 KR 102186403B1
- Authority
- KR
- South Korea
- Prior art keywords
- electric field
- radiation
- cancer
- treatment
- radiation therapy
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36153—Voltage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
본 발명은 교류 전기장과 방사선 치료의 융합을 이용한 암 치료 방법에 관한 것으로, 더욱 자세하게는 교류 전기장을 방사선 치료 시작 전에 일정시간 부가하여 방사선 치료의 효과를 극대화할 수 있는 암 치료 방법에 관한 것이다. 본 발명에 따르면, 정상조직에 대한 부작용은 감소시키는 동시에 암세포에는 방사선 치료의 효과를 극대화시킬 수 있으므로, 정상조직에 부작용이 거의 없는 적은 양의 전기장 및 방사선으로 효과적인 암치료 방법 구축이 가능하다.The present invention relates to a cancer treatment method using the fusion of an alternating current electric field and radiation therapy, and more particularly, to a cancer treatment method capable of maximizing the effect of radiation therapy by adding an alternating electric field for a predetermined time before the start of radiation treatment. According to the present invention, since side effects on normal tissues can be reduced and the effect of radiation treatment on cancer cells can be maximized, it is possible to establish an effective cancer treatment method with a small amount of electric field and radiation with little side effects on normal tissues.
Description
본 발명은 교류 전기장과 방사선 치료의 융합을 이용한 암 치료 방법에 관한 것으로, 더욱 자세하게는 교류 전기장을 방사선 치료 시작 전에 일정시간 부가하여 방사선 치료의 효과를 극대화할 수 있는 암 치료 방법에 관한 것이다.The present invention relates to a cancer treatment method using the fusion of an alternating current electric field and radiation therapy, and more particularly, to a cancer treatment method capable of maximizing the effect of radiation therapy by adding an alternating electric field for a predetermined time before the start of radiation treatment.
현재 암 환자 중 국내 35 %, 미국의 경우 50 % 정도가 방사선 치료를 받고 있으며, 국내에서도 방사선 치료를 받는 암 환자의 비중이 꾸준히 증가하고 있고, 암치료에 있어 방사선 치료의 중요성 또한 증가하고 있다. 이와 같이 방사선 치료는 현재 다양한 종류의 암에 필수적인 치료방법으로 알려져 있으나 암세포의 방사선 저항성, 저산소증 세포의 존재는 종래 암 방사선치료에서 국부적 실패를 일으키는 중요한 인자이다(Int. J. Radiation oncology Biol. Phys., 1988, 14, 831-833). 또한, 이러한 방사선 항암 치료의 실패에 따라 방사선량을 증가시킨 고선량 방사선 조사 치료 시 인체 정상조직의 파괴 등 방사선 치료의 부작용이 나타나는 문제점이 대두되었다. Currently, 35% of cancer patients in Korea and 50% in the United States are receiving radiation therapy, and the proportion of cancer patients receiving radiation therapy in Korea is steadily increasing, and the importance of radiation therapy in cancer treatment is also increasing. As such, radiation therapy is currently known as an essential treatment method for various types of cancer, but radiation resistance of cancer cells and the presence of hypoxia cells are important factors that cause local failure in conventional cancer radiation therapy (Int. J. Radiation oncology Biol. Phys. , 1988, 14, 831-833). In addition, as a result of the failure of such radiation chemotherapy, a problem has emerged in which side effects of radiation therapy, such as destruction of normal human tissues, appear when high-dose radiation treatment with increased radiation dose.
따라서, 방사선 치료시 그 효율성을 증대시킬 수 있는 방사선 치료 증진제 및 방사선 증감성 화합물에 관한 연구들이 계속 진행되고 있다(Oncogene, 2004, 23, 1599-1607; Int. J. Radiation Oncology Biol. Phys., 2006, 64(5), 1466-1474; Clin, Cancer Res, 2007, 13(16), 4891-4899). 현재까지 보고된 방사선 치료 증진제는 주로 항암제로 알려진 탁솔(Taxol), 시스플라틴(cisplatin), 플루오로우라실(Fluorouracil: 5-Fu), 류프롤리드(Leuprolide) 등이 유방암, 자궁암, 위암, 난소암, 폐암, 전립선암, 대장암 등 여러 고형암등에서 방사선 치료 증진제로서 연구되었으며, 이러한 화합물 투여와 방사선 치료를 병행하였을 때 방사선의 치료 효율이 증진된다는 것이 입증되었다(Oncology Rep. 2006 16: 1085-1091; Int J Radiat Oncol Biol Phys. 2006, 1, 64(5), 1466-1474; Clin Cancer Res. 2005, 1, 11(19), 7047-7052; Int J Radiat Biol. 2007, 83(1), 41-47).Therefore, studies on radiotherapy enhancers and radiosensitizing compounds that can increase the efficiency of radiation therapy are ongoing (Oncogene, 2004, 23, 1599-1607; Int. J. Radiation Oncology Biol. Phys., 2006, 64(5), 1466-1474; Clin, Cancer Res, 2007, 13(16), 4891-4899). Radiotherapy enhancers reported to date include Taxol, cisplatin, Fluorouracil (5-Fu), and Leuprolide, which are mainly known as anticancer drugs. It has been studied as a radiotherapy enhancer in various solid cancers such as lung cancer, prostate cancer, and colon cancer, and it has been demonstrated that the treatment efficiency of radiation is improved when the administration of these compounds and radiation therapy are combined (Oncology Rep. 2006 16: 1085-1091; Int. J Radiat Oncol Biol Phys. 2006, 1, 64(5), 1466-1474; Clin Cancer Res. 2005, 1, 11(19), 7047-7052; Int J Radiat Biol. 2007, 83(1), 41- 47).
그러나, 위에서 언급한 항암제들은 다양한 암세포 조직에서 방사선 치료 증진 효과를 나타내지 못할 뿐 아니라 항암제 부작용 또한 큰 것으로 나타나고 있어, 새로운 방사선 치료 증진 방법의 개발이 요구되고 있다.However, the above-mentioned anticancer drugs do not show a radiation treatment enhancing effect in various cancer cell tissues, and also have a large side effect of anticancer drugs, and thus, the development of a new radiation treatment enhancement method is required.
최근 교류 전기장을 이용하여 암세포의 세포분열을 억제시켜 암을 치료하고자 하는 연구가 진행 중이다. 세포의 분열은 쌍극자 모멘트를 지닌 미세소관(microtubules)들이 분열시 전기적 힘에 의해 서로 결합하여 방추사(spindle)를 형성하고, 생성된 방추사가 세포 중앙에 배열된 염색체를 양쪽으로 잡아당겨 세포분열이 이루어진다. 만약, 이러한 세포분열을 암세포에서 지연시킨다면 암세포의 세포분열 억제를 통한 암의 치료가 가능하다. 세포 외부의 인가 전기장이 방추사를 형성하기 위한 미세소관의 움직임을 통제할 수 있으며, 전기장에 의해 방추사가 제대로 형성되지 못한 세포는 정상적인 세포분열이 이루어지지 못한다. Recently, research to treat cancer by inhibiting cell division of cancer cells using an alternating electric field is ongoing. In the division of cells, microtubules with dipole moments combine with each other by electrical force during division to form a spindle, and the generated spindle pulls the chromosomes arranged in the center of the cell to both sides, resulting in cell division. . If such cell division is delayed in cancer cells, it is possible to cure cancer by inhibiting cell division of cancer cells. The applied electric field outside the cell can control the movement of the microtubules to form the spindle, and cells in which the spindle is not properly formed due to the electric field do not undergo normal cell division.
이에, 본 발명자들은 부작용이 적으며, 다양한 암세포 조직에서 방사선 치료 증진 효과를 나타낼 수 있는 치료방법을 찾고자 예의 노력한 결과, 교류 전기장을 방사선 치료 시작 전에 일정시간 부가하여 방사선 치료의 효과를 극대화 시킬 수 있는 것을 확인하고, 본 발명을 완성하게 되었다.Accordingly, the present inventors have made diligent efforts to find a treatment method that has fewer side effects and can exhibit a radiation treatment enhancing effect in various cancer cell tissues. As a result, the effect of radiation treatment can be maximized by adding an alternating electric field for a certain time before the start of radiation treatment. After confirming that, the present invention was completed.
본 발명의 목적은 교류전압발생기 및 전기패드를 포함하는 교류전기장 발생 시스템과 방사선 장치가 융합된 의료장치로, 상기 교류전압발생기는 함수발생기(Function generator) 제어용 컴퓨터; 함수발생기; 전압 증폭기(Voltage amplifier); 및 오실로스코프(Oscilloscope)를 포함하며, 상기 교류전압발생기의 전압은 1~250V이고, 주파수는 1~250kHz이고, 전기장 발생 시간은 1~72시간인 것을 특징으로 하는 교류전기장 발생 시스템과 방사선 장치가 융합된 암 치료용 의료장치를 이용한 암 치료 방법을 제공하는 데 있다.An object of the present invention is a medical device in which a radiation device and an AC electric field generating system including an AC voltage generator and an electric pad are fused, wherein the AC voltage generator includes a computer for controlling a function generator; Function generator; A voltage amplifier; And an oscilloscope, wherein the AC voltage generator has a voltage of 1 to 250 V, a frequency of 1 to 250 kHz, and an electric field generation time of 1 to 72 hours. It is to provide a cancer treatment method using a medical device for cancer treatment.
상기 목적을 달성하기 위하여, 본 발명은 교류전압발생기 및 전기패드를 포함하는 교류전기장 발생 시스템과 방사선 장치가 융합된 의료장치로, 상기 교류전압발생기는 함수발생기(Function generator) 제어용 컴퓨터; 함수발생기; 전압 증폭기(Voltage amplifier); 및 오실로스코프(Oscilloscope)를 포함하며, 상기 교류전압발생기의 전압은 1~250V이고, 주파수는 1~250kHz이고, 전기장 발생 시간은 1~72시간인 것을 특징으로 하는 교류전기장 발생 시스템과 방사선 장치가 융합된 암 치료용 의료장치를 제공한다.In order to achieve the above object, the present invention is a medical device in which an AC electric field generating system including an AC voltage generator and an electric pad and a radiation device are fused, wherein the AC voltage generator includes a computer for controlling a function generator; Function generator; A voltage amplifier; And an oscilloscope, wherein the AC voltage generator has a voltage of 1 to 250 V, a frequency of 1 to 250 kHz, and an electric field generation time of 1 to 72 hours. It provides a medical device for cancer treatment.
본 발명은 또한, (a) 전압 1~250V 및 주파수 1~250kHz인 교류 전기장을 치료부위에 1~72시간 인가하는 단계; 및 (b) 상기 교류 전기장이 인가된 치료부위에 방사선을 추가로 조사하는 단계를 포함하는 암 치료 방법을 제공한다.The present invention also includes the steps of: (a) applying an AC electric field having a voltage of 1 to 250V and a frequency of 1 to 250 kHz to the treatment site for 1 to 72 hours; And (b) it provides a method for treating cancer comprising the step of additionally irradiating the treatment area to which the AC electric field is applied.
본 발명에 따르면, 정상조직에 대한 부작용은 감소시키는 동시에 암세포에는 방사선 치료의 효과를 극대화시킬 수 있으므로, 정상조직에 부작용이 거의 없는 적은 양의 전기장 및 방사선으로 효과적인 암치료 방법 구축이 가능하다.According to the present invention, since side effects on normal tissues can be reduced and the effect of radiation treatment on cancer cells can be maximized, it is possible to establish an effective cancer treatment method with a small amount of electric field and radiation with little side effects on normal tissues.
도 1은 연속적인 전기장에 의한 암 치료와 방사선 치료를 융합한 암치료 방법에 대한 것을 도식도로 나타낸 것이다.
도 2는 암세포에 대한 전기장 효과를 확인하기 위한 실험 개요도이다.
도 3은 전기장과 방사선 치료를 융합하여 뇌암에 대한 시너지 효과를 확인한 결과이다. (a) U373 세포, (b) U87 세포.
도 4는 방사선 치료 단독 및 전기장과 방사선의 융합치료에서 세포생존률을 확인한 결과이다. (a) U373 세포, (b) U87 세포.
도 5는 방사선과 전기장의 융합치료에서 전기장치료기 고정장치를 나타낸 모식도이다.
1 is a schematic diagram showing a cancer treatment method in which cancer treatment by a continuous electric field and radiation treatment are combined.
2 is a schematic diagram of an experiment for confirming the effect of an electric field on cancer cells.
3 is a result of confirming the synergistic effect on brain cancer by fusion of electric field and radiation treatment. (a) U373 cells, (b) U87 cells.
4 is a result of confirming the cell viability in radiation therapy alone and in fusion therapy of electric field and radiation. (a) U373 cells, (b) U87 cells.
5 is a schematic diagram showing a device for fixing an electric device in a fusion therapy of radiation and an electric field.
다른 식으로 정의되지 않는 한, 본 명세서에서 사용된 모든 기술적 및 과학적 용어들은 본 발명이 속하는 기술 분야에서 숙련된 전문가에 의해서 통상적으로 이해되는 것과 동일한 의미를 가진다. 일반적으로, 본 명세서에서 사용된 명명법은 본 기술 분야에서 잘 알려져 있고 통상적으로 사용되는 것이다.Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by an expert skilled in the art to which the present invention belongs. In general, the nomenclature used in this specification is well known and commonly used in the art.
본 발명에서는, 함수발생기(Function generator) 제어용 컴퓨터; 함수발생기; 전압 증폭기(Voltage amplifier); 및 오실로스코프(Oscilloscope)를 포함하는 교류전압발생기를 이용하여 전압은 1~250V, 주파수는 1~250kHz의 교류 전기장을 치료부위에 1~72시간 동안 인가한 후, 상기 교류 전기장이 인가된 치료부위에 방사선을 추가로 조사하여 세포에 전기장과 방사선을 융합하여 적용하였다.In the present invention, a computer for controlling a function generator; Function generator; A voltage amplifier; And an AC voltage generator including an oscilloscope, after applying an AC electric field with a voltage of 1 to 250 V and a frequency of 1 to 250 kHz to the treatment site for 1 to 72 hours, to the treatment site to which the AC electric field is applied. Radiation was further irradiated and applied by fusion of electric field and radiation to cells.
따라서, 본 발명은 일 관점에서 교류전압발생기 및 전기패드를 포함하는 교류전기장 발생 시스템과 방사선 장치가 융합된 의료장치로, 상기 교류전압발생기는 함수발생기(Function generator) 제어용 컴퓨터; 함수발생기; 전압 증폭기(Voltage amplifier); 및 오실로스코프(Oscilloscope)를 포함하며, 상기 교류전압발생기의 전압은 1~250V이고, 주파수는 1~250kHz이고, 전기장 발생 시간은 1~72시간인 것을 특징으로 하는 교류전기장 발생 시스템과 방사선 장치가 융합된 암 치료용 의료장치에 관한 것이다.Accordingly, in one aspect, the present invention is a medical device in which an AC electric field generating system including an AC voltage generator and an electric pad and a radiation device are fused, wherein the AC voltage generator includes a computer for controlling a function generator; Function generator; A voltage amplifier; And an oscilloscope, wherein the AC voltage generator has a voltage of 1 to 250 V, a frequency of 1 to 250 kHz, and an electric field generation time of 1 to 72 hours. It relates to a medical device for cancer treatment.
본 발명에 있어서, 상기 전압은 5~100V인 것이 바람직하나, 이에 한정되는 것은 아니다.In the present invention, the voltage is preferably 5 ~ 100V, but is not limited thereto.
본 발명에 있어서, 상기 주파수는 100~200kHz인 것이 바람직하나, 이에 한정되는 것은 아니다.In the present invention, the frequency is preferably 100 to 200 kHz, but is not limited thereto.
본 발명에 있어서, 상기 전기장 발생 시간은 12~36시간인 것이 바람직하나, 이에 한정되는 것은 아니다.In the present invention, the electric field generation time is preferably 12 to 36 hours, but is not limited thereto.
본 발명에 있어서, 상기 교류전기장은 연속적으로 발생되는 것이 바람직하나, 이에 한정되는 것은 아니다.In the present invention, it is preferable that the AC electric field is continuously generated, but is not limited thereto.
본 발명은 다른 관점에서, 전압 1~250V 및 주파수 1~250kHz인 교류 전기장을 치료부위에 1~72시간 인가하는 단계; 및 상기 교류 전기장이 인가된 치료부위에 방사선을 추가로 조사하는 단계를 포함하는 암 치료 방법에 관한 것이다.In another aspect, the present invention comprises the steps of applying an AC electric field having a voltage of 1 to 250V and a frequency of 1 to 250kHz to the treatment site for 1 to 72 hours; And it relates to a method for treating cancer comprising the step of additionally irradiating the treatment area to which the AC electric field is applied.
본 발명은 암을 치료하기 위한 목적으로 방사선 치료를 할 때 교류 전기장을 치료 시작 전에 종양 부위에 일정시간 부과하여 방사선 치료의 효과를 극대화시키는 기술에 관한 것이다.The present invention relates to a technique for maximizing the effect of radiation treatment by imposing an alternating current electric field on a tumor site for a certain period of time before the start of treatment when performing radiation treatment for the purpose of treating cancer.
교류 전기장을 세포분열 중인 암세포에 인가하면 암세포가 분열하는 것을 억제하거나 암세포의 괴사를 유도할 수 있으므로, 본 발명에서는 컴퓨터 프로그래밍을 이용하여 교류 전기장의 크기, 주파수, 시간 등을 조절하여 방사선 치료의 효과를 극대화시킬 수 있다. 특정 암에서는 방사선 단독으로는 치료의 한계가 있어, 이러한 문제를 해결하기 위해 항암 치료와 방사선 치료를 융합하기도 하는데, 이 경우 방사선 단독보다 우수한 치료 효과를 나타내기도 한다. 따라서, 교류 전기장과 항암 치료를 융합하여 암을 치료할 경우 치료 효과가 보다 더 극대화될 수 있으며, 방사선 치료와 전기장 치료의 융합은 현저히 효과가 우수한 융합 암치료 방법으로 기대된다. If an alternating current electric field is applied to cancer cells in dividing cells, it is possible to inhibit the division of cancer cells or induce necrosis of the cancer cells.Therefore, in the present invention, the effect of radiation treatment by controlling the magnitude, frequency, and time of the alternating electric field using computer programming. Can be maximized. In certain cancers, radiation alone has limitations in treatment, and to solve this problem, chemotherapy and radiation therapy are combined, and in this case, the treatment effect is superior to that of radiation alone. Therefore, when treating cancer by fusion of an alternating current electric field and chemotherapy, the therapeutic effect can be further maximized, and the fusion of radiation therapy and electric field therapy is expected to be a remarkably effective fusion cancer treatment method.
현재 연구되고 있는 전기장 또는 방사선을 이용한 암 치료법은 전상조직을 보호할 수 있는 방안에 대한 체계가 갖춰져 있지 않아, 실질적으로 부작용이 나타나기 전가지는 정상조직에 대한 피해를 알 수 없는 실정이다. 하지만, 본 발명의 전기장과 방사선의 융합 치료 시스템이 적용되면 전기장 및 방사선의 양이 확연히 줄어들게 되어 정상조직에 대한 피해를 현저히 감소시킬 수 있다. 따라서, 교류 전기장과 방사선을 융합하여 암을 치료할 경우 정상 조직의 부작용 때문에 치료할 수 없었던 종양에도 항암치료를 적용할 수 있어 현 방사선 치료의 문제점을 개선할 수 있다.Cancer treatment using electric field or radiation currently being studied does not have a system for protecting injured tissues, so it is impossible to know the damage to normal tissues before actual side effects appear. However, when the fusion treatment system of electric field and radiation of the present invention is applied, the amount of electric field and radiation is remarkably reduced, so that damage to normal tissues can be significantly reduced. Therefore, when cancer is treated by fusion of an alternating current electric field and radiation, chemotherapy can be applied to tumors that could not be treated due to side effects of normal tissues, thereby improving the problems of current radiation therapy.
[실시예][Example]
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail through examples. These examples are for illustrative purposes only, and it will be apparent to those of ordinary skill in the art that the scope of the present invention is not construed as being limited by these examples.
실시예Example 1: 교류전기장과 방사선 치료의 융합에 의한 세포의 변화 1: Changes in cells due to the fusion of AC electric field and radiation therapy
본 실시예에서는 암 치료시 방사선 조사에 의한 부작용을 최소화하여 정상조직을 보호할 수 있는 시스템을 개발하기 위하여, 방사선 조사 전에 종양 부위에 전기장을 인가하여 암세포에 대한 방사선 치료의 효과를 극대화시킬 수 있는 교류전기장 발생 시스템과 방사선 장치가 융합된 암 치료 시스템을 개발하였다.In this embodiment, in order to develop a system that can protect normal tissues by minimizing side effects caused by radiation irradiation during cancer treatment, an electric field is applied to the tumor site before radiation to maximize the effect of radiation treatment on cancer cells. A cancer treatment system was developed in which an alternating current electric field generating system and a radiation device were combined.
도 2는 교류 전기장이 가해질 때 암세포의 변화를 확인하는 실험의 개요도이다. 함수 발생기(Function generator)로부터 발생되는 전기장을 증폭기(Amplifier)로 증폭시켜 고전압을 획득한 후 이 전압을 배양액 속의 세포를 담고 있는 절연전선(Insulated wires) 사이에 적용시키면 세포는 일정량의 전기장에 의한 영향을 받게 된다. 보통의 경우 전기장을 이용하여 암세포의 세포분열 억제를 유도하고자 할 때에는 48-72시간 정도 연속적인 전기장을 암세포에 적용시켜 주며, 이러한 전기장을 이용하여 암치료를 선행적으로 진행시키고 방사선 치료를 진행하였다.2 is a schematic diagram of an experiment to confirm changes in cancer cells when an alternating electric field is applied. When the electric field generated from the function generator is amplified with an amplifier to obtain a high voltage and then applied between the insulated wires containing the cells in the culture medium, the cells are affected by a certain amount of electric field. Will receive. In general, in order to induce the inhibition of cell division of cancer cells by using an electric field, a continuous electric field for 48-72 hours was applied to the cancer cells, and cancer treatment was preceded and radiation treatment was performed using this electric field. .
도 5는 방사선치료와 전기장치료를 동시에 받을 수 있게 만든 장치로, 환자테이블 끝부분에 전기장치료기 고정장치를 부착하고 환자가 사용한 전기장치료기를 끼워서 사용할 수 있다. 고정장치는 테이블에 쉽게 부착이 가능하며, 환자가 사용한 전기치료기 그대로 사용할 수 있으므로, 중간에 전기장치료를 멈출 필요 없이 방사선치료와 동시에 진행이 가능하다.FIG. 5 is a device made to receive radiation treatment and electrical device charges at the same time, and the electrical device device fixing device may be attached to the end of the patient table, and the electrical device device used by the patient may be inserted. The fixing device can be easily attached to the table, and since the electric treatment device used by the patient can be used as it is, it is possible to proceed simultaneously with the radiation treatment without having to stop the electric equipment charge in the middle.
악성신경교종 세포주 U373 및 U87에 외부전압 50V, 주파수 150kHz의 전기장을 24시간 동안 인가한 후, 방사선을 3~6 Gy 조사하였다. 그 결과, 도 3 및 도 4에 나타난 바와 같이, 방사선 단독 또는 전기장 단독 치료보다 전기장과 방사선의 융합 치료에서 세포 생존율이 훨씬 감소하는 것을 알 수 있었다. 또한 항암제(pcalitaxel, doxorubicin, cyclophsphamide)를 1.75V/cm의 전기장을 72시간 동안 MDA-MB 세포에 인가하여 나타난 효과 (Kirson et al., BMC Medical Physics 9:1, 2009)와 비교해볼 때, 암 세포 종류에 따라 비슷하거나 약간 더 높았다. 전기장과 방사선 융합 치료 방법을 뇌암과 같이 수술하기 어려운 위치에 종양이 존재하거나 항암치료 또는 방사선치료 효과가 매우 적은 종양에 적용한다면 큰 효과를 발휘할 수 있는 가능성을 알 수 있었다.An electric field with an external voltage of 50 V and a frequency of 150 kHz was applied to the malignant glioma cell lines U373 and U87 for 24 hours, and then 3 to 6 Gy of radiation was irradiated. As a result, as shown in FIGS. 3 and 4, it was found that the cell survival rate was significantly reduced in the fusion treatment of the electric field and the radiation than the radiation alone or the electric field alone treatment. In addition, anticancer drugs (pcalitaxel, doxorubicin, cyclophsphamide) were applied to MDA-MB cells in an electric field of 1.75V/cm for 72 hours. Compared with the effect of application (Kirson et al., BMC Medical Physics 9:1, 2009), it was similar or slightly higher depending on the cancer cell type. If the electric field and radiation fusion treatment method is applied to a tumor in a location that is difficult to operate, such as brain cancer, or to a tumor that has very little effect of chemotherapy or radiotherapy, it was found that it could have a great effect.
즉, 항암제와 전기장의 동시치료 효과에 비해, 전기장을 이용해 먼저 암치료를 한 후 방사선 치료를 진행했을 때 암세포의 생존을 훨씬 효과적으로 감소시킬 수 있음을 보여주는 결과이므로, 본 발명의 시스템인 방사선 치료를 하기 전에 전기장을 연속적으로 일정시간 가해주면 치료효과를 획기적으로 개선할 수 있을 것으로 기대된다.That is, compared to the simultaneous treatment effect of an anticancer agent and an electric field, it is a result that shows that the survival of cancer cells can be reduced much more effectively when cancer treatment is first performed using an electric field and then radiation treatment is performed. It is expected that the therapeutic effect can be dramatically improved if an electric field is continuously applied for a certain period of time before the treatment.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적 기술은 단지 바람직한 실시태양일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.As described above, specific parts of the present invention have been described in detail, and it is obvious that these specific techniques are only preferred embodiments for those of ordinary skill in the art, and the scope of the present invention is not limited thereby. something to do. Accordingly, it will be said that the substantial scope of the present invention is defined by the appended claims and their equivalents.
Claims (5)
A medical device in which an AC electric field generating system including an AC voltage generator and an electric pad and a radiation device are fused, wherein the AC voltage generator includes a function generator and a voltage amplifier, and the voltage of the AC voltage generator is 50 to 100V, A medical device for killing or inhibiting the growth of brain cancer cells in which an alternating current electric field generating system and a radiation device are fused, characterized in that the frequency is 100 to 200 kHz and the electric field generation time is 12 to 36 hours before each radiation treatment.
The medical device of claim 1, wherein the alternating electric field is continuously generated.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150125412A KR102186403B1 (en) | 2015-09-04 | 2015-09-04 | Method for Treating Cancer Using Alternative Electric Field in Combination with Radiation Therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150125412A KR102186403B1 (en) | 2015-09-04 | 2015-09-04 | Method for Treating Cancer Using Alternative Electric Field in Combination with Radiation Therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170028601A KR20170028601A (en) | 2017-03-14 |
KR102186403B1 true KR102186403B1 (en) | 2020-12-04 |
Family
ID=58460086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150125412A KR102186403B1 (en) | 2015-09-04 | 2015-09-04 | Method for Treating Cancer Using Alternative Electric Field in Combination with Radiation Therapy |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102186403B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102644003B1 (en) | 2020-04-01 | 2024-03-07 | 한국전자통신연구원 | Cancer treatment device |
KR102464313B1 (en) | 2020-05-18 | 2022-11-08 | 주식회사 필드큐어 | Apparatus and Method for Quality Assurance in Electric Field Therapy |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006513739A (en) | 2002-10-02 | 2006-04-27 | スタンデン・リミテッド | Device for treating tumors and the like, and a product equipped with a device for treating tumors |
JP2011224102A (en) | 2010-04-19 | 2011-11-10 | Kumamoto Univ | Method of inducing apoptosis or the like using nanosecond pulse electric field |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080059821A (en) * | 2006-12-26 | 2008-07-01 | 삼성전자주식회사 | Apparatus of maintaining freshness by applying asymmetric electric field |
-
2015
- 2015-09-04 KR KR1020150125412A patent/KR102186403B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006513739A (en) | 2002-10-02 | 2006-04-27 | スタンデン・リミテッド | Device for treating tumors and the like, and a product equipped with a device for treating tumors |
JP2011224102A (en) | 2010-04-19 | 2011-11-10 | Kumamoto Univ | Method of inducing apoptosis or the like using nanosecond pulse electric field |
Also Published As
Publication number | Publication date |
---|---|
KR20170028601A (en) | 2017-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brundha et al. | Quantitative changes of red blood cells in cancer patients under palliative radiotherapy-a retrospective study | |
Prezado et al. | Tolerance to dose escalation in minibeam radiation therapy applied to normal rat brain: long-term clinical, radiological and histopathological analysis | |
Edhemovic et al. | Intraoperative electrochemotherapy of colorectal liver metastases | |
Kong et al. | Reirradiation of locally recurrent nasopharyngeal cancer: history, advances, and promises for the future | |
Schild et al. | Proton beam therapy for locally advanced lung cancer: A review | |
Ruge et al. | Comparison of Stereotactic Brachytherapy (^ sup 125^ Iodine Seeds) with Stereotactic Radiosurgery (LINAC) for the Treatment of Singular Cerebral Metastases | |
Cox et al. | Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis | |
Martínez‐Rovira et al. | Monte Carlo dose enhancement studies in microbeam radiation therapy | |
Schoenfeld et al. | Abbreviated course of radiotherapy (RT) for breast cancer | |
PH12015502260A1 (en) | C. novyi for the treatment of solid tumors in humans | |
Snoj et al. | Effective treatment of multiple unresectable skin melanoma metastases by electrochemotherapy | |
KR102186403B1 (en) | Method for Treating Cancer Using Alternative Electric Field in Combination with Radiation Therapy | |
Oshiro et al. | Proton beam therapy interference with implanted cardiac pacemakers | |
Krivoshapkin et al. | Repeat resection and intraoperative radiotherapy for malignant gliomas of the brain: a history and review of current techniques | |
WO2021127556A8 (en) | Methods for treating cancer comprising low dose radiation | |
Shinohara et al. | Optimization of X-ray microplanar beam radiation therapy for deep-seated tumors by a simulation study | |
Johnsrud et al. | General principles of SFRT biology | |
Mowlavi et al. | Calculation of energy deposition, photon and neutron production in proton therapy of thyroid gland using MCNPX | |
Hajar et al. | An unusual case of nasopharyngial adenoid cystic carcinoma with intracranial and orbital extension: a challenge for innovative conformal radiotherapy techniques | |
Larson | Introduction to Stereotactic Radiosurgery and Stereotactic Body Radiotherapy | |
Pedroso et al. | Preliminary Novalis experience in the treatment of skull base chordomas with stereotactic radiosurgery and stereotactic radiotherapy | |
Monzen et al. | Electron beam SFRT | |
Valpione et al. | Phase I/II study of electrochemotherapy with intravenous bleomycin and variable geometry electric fields for the treatment of deep and large soft tissue tumors | |
Fiorentini et al. | Abscopal effect: new perspectives in Oncothermia | |
Sidy et al. | Role of specific cancer treatments in pain management |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |